A point-of-care malaria drug resistance assay (UC Berkeley)

Facebook
Twitter
LinkedIn

BI Filler Photo-01We propose to develop a palm-sized microfluidic device which permits culturing of malaria-infected red blood cells under physiological conditions in suspension. The extent of parasitemia is determined by a label-free magneto-optic technique. Such a device will enable point-of-care antibiotic resistance assays for testing different malarial strains primarily targeting countries in the developing world.

More Winners

Hyoumanity (UC Berkeley)

Patients facing the most complex and difficult diagnoses sometimes see dozens of doctors and spend years searching for answers. Ultimately, resolving many of these cases

Read More »

Lifenik (UC Berkeley)

In the United States, suicide rates have increased 60% over the last 50 years, depression is predicted to be the second-most prevalent health condition in

Read More »

© 2021 Blum Center for Developing Economies

Design by Joseph Kim